ERNA (Ernexa Therapeutics) Float Percentage Of Total Shares Outstanding: 62.79% (As of Jul. 04, 2026)


ERNA Ernexa Therapeutics Inc ERNA
30 GF Score
Price $6.45
! 4 Warning Signs
View Full Analysis

What is Ernexa Therapeutics Float Percentage Of Total Shares Outstanding?

Ernexa Therapeutics ERNA -6.48% 30 Float Percentage Of Total Shares Outstanding is 62.79% as of Jul. 04, 2026. GuruFocus rates ERNA with a GF Score™ of 30/100. The stock has 4 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Ernexa Therapeutics's float shares is 0.73 Mil. Ernexa Therapeutics's total shares outstanding is 1.17 Mil. Ernexa Therapeutics's float percentage of total shares outstanding is 62.79%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Ernexa Therapeutics's Insider Ownership is 27.83%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Ernexa Therapeutics's Institutional Ownership is 12.38%.

ERNA
30GF Score
Ernexa Therapeutics Inc ERNA
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ernexa Therapeutics Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Ernexa Therapeutics's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.73/1.17
=62.79%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 62.79% mean?
Ernexa Therapeutics (ERNA) has a Float Percentage Of Total Shares Outstanding of 62.79% as of Jul. 04, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Ernexa Therapeutics and its competitors.
Is Ernexa Therapeutics' Float Percentage Of Total Shares Outstanding too high?
Ernexa Therapeutics' current Float Percentage Of Total Shares Outstanding is 62.79%. Overall, Ernexa Therapeutics has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Ernexa Therapeutics' Float Percentage Of Total Shares Outstanding compare to PMCB and SYBX?
Ernexa Therapeutics' Float Percentage Of Total Shares Outstanding of 62.79% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Ernexa Therapeutics and its competitors. Ernexa Therapeutics's current Float Percentage Of Total Shares Outstanding is 62.79%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ernexa Therapeutics stock overvalued right now?
Ernexa Therapeutics (ERNA) has a current Float Percentage Of Total Shares Outstanding of 62.79%. The current Float Percentage Of Total Shares Outstanding is 62.79%. Ernexa Therapeutics' overall GF Score™ is 30/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Ernexa Therapeutics (ERNA), the current Float Percentage Of Total Shares Outstanding is 62.79% as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ernexa Therapeutics Business Description

Address 1035 Cambridge Street, Suite 18A, Cambridge, MA, USA, 02141
Ernexa Therapeutics Inc is a preclinical-stage synthetic allogeneic iMSC therapy company developing medicines to treat various forms of cancer and other diseases with high unmet medical needs. Its main product candidate, ERNA-101, capitalizes on the intrinsic tumor-homing ability of MSCs (mesenchymal stem cells) to slip through the tumor's defenses and to deliver potent pro-inflammatory factors directly to the tumor microenvironment. The firm's initial focus is to develop ERNA-101 in platinum-resistant ovarian cancer. Through another product candidate, ERNA-201, it is investigating anti-inflammatory cytokine (IL-10) secreting iMSCs in autoimmune disorders like rheumatoid arthritis. The company operates in a single reportable segment, the research and development of cellular therapies.
30GF Score

Get the complete analysis for ERNA

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.45
Price